Report of the Joint Allocation Taskforce - on the distribution of COVAX Facility secured vaccines: 6 July 2021

COVAX Allocation Round 5 concerns the allocation of COVAX Facility secured supplies of Pfizer BioNTech - Comirnaty (“Pfizer”)1 for the period of July to September 2021 (Q3-2021). The available supply of Pfizer in this Round includes 12,190,230 doses secured through the COVAX Facility advance purchase agreement with the manufacturer. An additional 59,999,940 doses are made available to the COVAX Facility for Q3-2021 allocation to the entire group of AMC participants as well as six SFPs in the African Union, through a procurement facilitated by the government of the United States of America (USG).

This allocation Round takes into account the coverage achieved by each participant thanks to the donations done through COVAX since Round 4. These donations will be delivered during Q3.